The Dermatology Digest

FEBRUARY 23, 2025

The U.S. Food and Drug Administration (FDA) approved chenodiol ( Ctexli , Mirum Pharmaceuticals Inc.) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Chenodiol is the first FDA-approved drug to treat CTX, a very rare lipid storage disease. CTX is a genetic metabolic disorder caused by a mutation in a gene called CYP27A1 resulting in a deficiency of the enzyme that is important in the bodys ability to break down fats.

Treatments 53

Treatments Pharmaceutical Clinic Dermatology 53

Aesthetics Advisor

FEBRUARY 23, 2025

Kate learned about topical steroid withdrawal when her son Alex stopped growing, and she took him off his eczema cream. Alexs eczema, also known as atopic dermatitis, began in infancy with small, itchy patches on his wrists and handsa condition Kate, a seasoned nurse, was familiar with. Following the doctors advice, she applied a mild corticosteroid cream.

Eczema 36

Eczema Dermatitis Medical Clinic 36

Dermatology Times

FEBRUARY 23, 2025

Explore the top headlines of the week including the expanding role of NPs and PAs, a clinicians guide to chemical peels, and recently announced therapeutic updates.

Chemical Peels 41

Chemical Peels 41

Dermatology Times

FEBRUARY 23, 2025

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Dermatology 41

Dermatology 41